7 Result(s)
within
Karin Milde-Langosch
English
Biomedicine, general
Cancer Research
Health Promotion and Disease Prevention
-
Article
Open AccessCorrection to: TGFB-induced factor homeobox 1 (TGIF) expression in breast cancer
-
Article
Open AccessTGFB-induced factor homeobox 1 (TGIF) expression in breast cancer
Breast cancer (BC) is the most frequent female cancer and preferentially metastasizes to bone. The transcription factor TGFB-induced factor homeobox 1 (TGIF) is involved in bone metabolism. However, it is not ...
-
Article
Open AccessElevated serum RAS p21 is an independent prognostic factor in metastatic breast cancer
An important component of the RAS signalling pathway, the RAS p21 oncogene, is frequently hyperactivated in breast cancer. Its expression in tumor tissue has been linked to poor clinical outcome. This study wa...
-
Article
Open AccessL1CAM is expressed in triple-negative breast cancers and is inversely correlated with Androgen receptor
Breast cancer is a heterogeneous disease displaying distinct molecular features and clinical outcome. The molecular profile of triple-negative breast cancers (TNBCs) overlaps with that of basal-like breast can...
-
Article
Open AccessRelevance of activated leukocyte cell adhesion molecule (ALCAM) in tumor tissue and sera of cervical cancer patients
An altered expression of the activated leukocyte cell adhesion molecule (ALCAM) is associated with cancer progression in various cancer types. In some cancers ALCAM has a prognostic value or is predictive for ...
-
Article
Open AccessCarbonic anhydrase IX in tumor tissue and sera of patients with primary cervical cancer
Carbonic anhydrase IX (CAIX) is a membranous expressed metalloenzyme involved in pH homeostasis and cell adhesion. The protein is overexpressed in a variety of tumors and potentially associated with negative o...
-
Article
Open AccessTIMP-1 and VEGF-165 serum concentration during first-line therapy of ovarian cancer patients
Angiogenesis appears to play an important role in ovarian cancer. Vascular endothelial growth factor (VEGF) has recently been implicated as a therapeutic target in ovarian cancer. The tissue inhibitor of metal...
